Calamos Advisors LLC Dexcom Inc Transaction History
Calamos Advisors LLC
- $16.8 Billion
- Q4 2024
A detailed history of Calamos Advisors LLC transactions in Dexcom Inc stock. As of the latest transaction made, Calamos Advisors LLC holds 175,507 shares of DXCM stock, worth $15.6 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
175,507
Previous 175,096
0.23%
Holding current value
$15.6 Million
Previous $11.7 Million
16.32%
% of portfolio
0.08%
Previous 0.07%
Shares
25 transactions
Others Institutions Holding DXCM
# of Institutions
1,040Shares Held
356MCall Options Held
5.51MPut Options Held
5.61M-
Vanguard Group Inc Valley Forge, PA47.4MShares$4.21 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.06 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.59 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.48 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.3 Billion0.9% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34.3B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...